Skip to main content
. Author manuscript; available in PMC: 2014 Sep 8.
Published in final edited form as: Anticancer Res. 2013 Oct;33(10):4475–4481.

Table III.

Treatment response.

Patient no. Duration of response (days) Best response (RECIST) Off-study reason
1 85 PD Grade 4 thrombocytopenia
2 45 PD Progressive disease
3 53 PD Progressive disease
4 119 SD Grade 3 QTc prolongation
5 25 PD Grade 4 neutropenia
6 53 PD Grade 4 neutropenia and thrombocytopenia